Search

H Lundbeck A-S

Avatud

29.42 -2.19

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

28.56

Max

30.08

Põhinäitajad

By Trading Economics

Sissetulek

-221M

590M

Müük

-181M

5.5B

P/E

Sektori keskmine

9.969

54.379

Aktsiakasum

1.36

Dividenditootlus

3.01

Kasumimarginaal

10.648

Töötajad

5,707

EBITDA

-193M

811M

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.01%

2.55%

Turustatistika

By TradingEconomics

Turukapital

31B

Eelmine avamishind

31.61

Eelmine sulgemishind

29.42

H Lundbeck A-S Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. mai 2025, 23:48 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11. mai 2025, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11. mai 2025, 23:45 UTC

Market Talk

Oil Rises Amid Improved Market Mood -- Market Talk

11. mai 2025, 23:38 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Aristocrat Has Significant Firepower for M&A -- Market Talk

11. mai 2025, 23:36 UTC

Market Talk

Global Markets Uncertain About US-China Trade News -- Market Talk

11. mai 2025, 23:35 UTC

Market Talk

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11. mai 2025, 23:33 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11. mai 2025, 23:32 UTC

Peamised uudised

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11. mai 2025, 22:44 UTC

Market Talk

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11. mai 2025, 22:33 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11. mai 2025, 20:19 UTC

Peamised uudised

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11. mai 2025, 16:00 UTC

Peamised uudised

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11. mai 2025, 11:00 UTC

Peamised uudised

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11. mai 2025, 08:00 UTC

Peamised uudised

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11. mai 2025, 01:00 UTC

Peamised uudised

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11. mai 2025, 01:00 UTC

Peamised uudised

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10. mai 2025, 21:54 UTC

Peamised uudised

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10. mai 2025, 17:12 UTC

Peamised uudised

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10. mai 2025, 15:41 UTC

Peamised uudised

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10. mai 2025, 12:00 UTC

Peamised uudised

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10. mai 2025, 09:30 UTC

Peamised uudised

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10. mai 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

10. mai 2025, 03:52 UTC

Peamised uudised

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9. mai 2025, 23:51 UTC

Omandamised, ülevõtmised, äriostud

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9. mai 2025, 22:06 UTC

Market Talk

Arm Holdings Remains a Strong Growth Story -- Market Talk

9. mai 2025, 21:37 UTC

Peamised uudised

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9. mai 2025, 21:10 UTC

Peamised uudised

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9. mai 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. mai 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

9. mai 2025, 20:42 UTC

Peamised uudised

Stocks Get a Break From Trade Chaos -- WSJ

H Lundbeck A-S Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest H Lundbeck A-S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.